5 курс / Психиатрия и наркология для детей и взрослых (доп.) / Шизофрения_Шмуклер_А_Б_2021_
.pdf
172 
ЛИТЕРАТУРА
96.Van Haren N.E., Hulshoff Pol H.E., Schnack H.G. et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood // Biol. Psychiatry. — 2008. — Vol. 63. — P. 106–113.
97.Van Haren N.E.M., Cahn W., Hulshoff Pol H.E., Kahn R.S. Schizophrenia as a progressive brain disease // Eur. Psychiatry. — 2008. — Vol. 23. — P. 245– 254.
98.Van Os J. A salience syndrome replaces schizophrenia in DSM-V and ICD10: psychiatry’s evidence-based entry into the 21st century? // Acta Psychiatr. Scand. — 2009. — Vol. 120. — N. 5. — P. 363–372.
99.Volkow N.D., Wolf A.P., Brodie J.D. Brain interactions in chronic schizophrenics under resting and activation conditions // Schizophr. Res. — 1988. — Vol. 1. — P. 47–53.
100.Wernicke C., Grundrisse der Psychiatrie. — Leipzig, Germany: Thieme. 1906.
101.Wible C.G., Preus A.P., Hashimoto R. A cognitive neuroscience view of schizophrenic symptoms: abnormal activation of a system for social perception and communication // Brain Imaging Behav. — 2009. — Vol. 3. — N. 1. — P. 85– 110.
102.Wing J.K., Cooper J.E., Sartorius N. The measurement and classification of psychiatric symptoms. — London: Cambridge University Press, 1974.
103.World Health Organization. WHO Model List of Essential Medicines 16th Edition, 2009. — http://www.who.int/medicines/publication/essentialmedicines/en/index/html.
104.Wyatt R.J., Alexander R.C., Egan M.F., Kirch D. Schizophrenia, just the facts. What do we know, how well do we know it? // Schizophr. Res. — 1988. — Vol. 1. — P. 3–18.